You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The grant is specifically intended to support the development of noninvasive, rapid tests that can be used at the point of care in developing country settings.
The funding builds on more than $1.7 million already awarded to the firm, which is building a diagnostic for characterizing patients in clinical trials.
The NSF and NIH awarded the firm separate grants to develop the system, which can provide results in five minutes from a drop of blood.
The company has received grant funding for diagnostic development projects, and is also seeking its first pharma service customers to provide nearer-term revenue.